Street Capital (STRC.X.CN) Stock Price

The Hash Corp. generates revenue through the production and sale of cannabis-based hashish and other cannabis products, collaborating with licensed cannabis cultivators. The company applies separation and curing techniques to create natural cannabis resin products without additives or carcinogenic solvents, targeting regulated markets. Its Hashishin brand utilizes refined trichome collection methods, while Medz serves as the product line for cannabis concentrates. The firm works with licensed cultivators to develop authentic traditional hashish products. The Hash Corp. offers services including separation, finishing, breeding programs, and product development, all aimed at producing high-quality cannabis resin products. The company's focus on traditional methods combined with modern applications ensures access to specific parts of the cannabis plant, enhancing product authenticity. Revenue streams come from direct sales of hashish and concentrates through its branded offerings in regulated markets. Hashishin and Medz are the primary product lines through which The Hash Corp. monetizes its cannabis resin production. The company's business model relies on partnerships with licensed cultivators to craft and distribute products, ensuring compliance with regulatory standards in the markets they operate. All products are marketed as natural, additive-free, and free of carcinogenic solvents, appealing to consumers seeking premium cannabis concentrates.